Q32 Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	53.74	53.74	-	-6.65	6.65	-
Revenue Growth	-	-	-	-	-	-
Cost of Revenue	14.35	19.16	48.14	31.73	35.81	29.93
Gross Profit	39.39	34.58	-48.14	-38.38	-29.16	-29.93
Selling, General & Admin	17.93	17.68	17.96	9.88	10.06	6.76
Operating Expenses	17.93	17.68	17.96	9.88	10.06	6.76
Operating Income	21.46	16.9	-66.1	-48.26	-39.23	-36.69
Interest Expense	-0.9	-1.1	-1.4	-2	-	-
Interest & Investment Income	1.78	2.2	3.9	-	-	-
Earnings From Equity Investments	-	-	-1.63	-	-	-
Other Non Operating Income (Expenses)	-0.08	0.16	2.3	3.02	-3.52	-0.32
EBT Excluding Unusual Items	22.27	18.16	-62.93	-47.23	-42.75	-37.02
Gain (Loss) on Sale of Investments	-0.07	-0.07	-0.68	-	-	-
Gain (Loss) on Sale of Assets	11.74	11.74	-	-	-	-
Other Unusual Items	-0.15	-	15.89	-6.19	-	-
Pretax Income	33.79	29.82	-47.71	-53.43	-42.75	-37.02
Income Tax Expense	-	-	0.02	0.32	0.06	0.55
Net Income	33.79	29.82	-47.73	-53.74	-42.81	-37.56
Net Income to Common	33.79	29.82	-47.73	-53.74	-42.81	-37.56
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	15	12	9	0	7	6
Shares Outstanding (Diluted)	15	12	10	0	7	6
Shares Change	21.91%	27.51%	2666.77%	-95.03%	8.57%	-
EPS (Basic)	2.28	2.42	-5.12	-153.96	-6.09	-5.81
EPS (Diluted)	2.27	2.42	-6.58	-153.96	-6.09	-5.81
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-19.83	-33.54	-67.79	-18.68	-13.44	-33.14
Free Cash Flow Per Share	-1.33	-2.72	-7.02	-53.52	-1.91	-5.12
Gross Margin	73.30%	64.35%	-	-	-	-
Operating Margin	39.94%	31.45%	-	-	-589.76%	-
Profit Margin	62.87%	55.49%	-	-	-643.65%	-
Free Cash Flow Margin	-36.90%	-62.42%	-	-	-202.10%	-
EBITDA	21.82	17.29	-65.62	-47.76	-38.86	-36.65
EBITDA Margin	40.60%	32.18%	-	-	-	-
D&A For EBITDA	0.36	0.39	0.49	0.5	0.37	0.05
EBIT	21.46	16.9	-66.1	-48.26	-39.23	-36.69
EBIT Margin	39.94%	31.45%	-	-	-	-

SEC Filings: 10-K · 10-Q